Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
DE Deere
- 464.510
- +8.070+1.77%
Close Apr 24 16:00 ET
- 464.510
- 0.0000.00%
Post 16:15 ET
126.07BMarket Cap20.57P/E (TTM)
466.510High456.970Low610.12KVolume458.520Open456.440Pre Close283.32MTurnover0.23%Turnover Ratio18.13P/E (Static)271.41MShares513.25752wk High5.61P/B125.81BFloat Cap336.53552wk Low6.03Dividend TTM270.84MShs Float513.257Historical High1.30%Div YieldTTM2.09%Amplitude8.409Historical Low464.372Avg Price1Lot Size
Deere Key Stats
Quarterly+Annual
YOY
| (Q1)Jan 26, 2025 | (FY)Oct 27, 2024 | (Q4)Oct 27, 2024 | (Q3)Jul 28, 2024 | (Q2)Apr 28, 2024 | (Q1)Jan 28, 2024 | (FY)Oct 29, 2023 | (Q4)Oct 29, 2023 | (Q3)Jul 30, 2023 | (Q2)Apr 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -30.25%8.26B | -16.15%50.52B | -28.57%10.83B | -17.31%12.85B | -12.59%15B | -4.44%11.85B | 17.48%60.25B | -0.78%15.16B | 12.21%15.54B | 33.73%17.16B |
| Operating revenue | -30.25%8.26B | -16.15%50.52B | -28.57%10.83B | -17.31%12.85B | -12.59%15B | -4.44%11.85B | 17.48%60.25B | -0.78%15.16B | 12.21%15.54B | 33.73%17.16B |
| Cost of revenue | -30.04%5.04B | -18.24%31.02B | -29.38%6.82B | -18.45%7.85B | -14.66%9.16B | -9.25%7.2B | 6.72%37.94B | -7.42%9.65B | 1.19%9.62B | 20.32%10.73B |
| Gross profit | -30.59%3.23B | -12.60%19.5B | -27.15%4.01B | -15.44%5B | -9.15%5.84B | 4.12%4.65B | 41.81%22.31B | 13.51%5.5B | 36.40%5.91B | 64.31%6.43B |
| Operating expense | -11.23%1.75B | 4.58%8.07B | 4.77%1.87B | 8.26%2.11B | -5.13%2.13B | 12.71%1.97B | 15.08%7.72B | 2.24%1.78B | 10.93%1.95B | 30.76%2.24B |
| Selling and administrative expenses | -8.82%972M | 4.60%4.51B | -1.96%899M | 15.14%1.28B | -4.89%1.27B | 11.97%1.07B | 18.22%4.31B | -5.76%917M | 15.75%1.11B | 42.70%1.33B |
| -General and administrative expense | ---- | 4.60%4.51B | ---- | ---- | ---- | ---- | 18.22%4.31B | ---- | ---- | ---- |
| Research and development costs | -1.31%526M | 5.19%2.29B | 3.30%626M | 7.39%567M | 3.29%565M | 7.68%533M | 13.86%2.18B | 5.21%606M | 9.77%528M | 20.75%547M |
| Depreciation amortization depletion | ---- | 2.46%874M | ---- | ---- | ---- | ---- | 3.14%853M | ---- | ---- | ---- |
| -Depreciation and amortization | ---- | 2.46%874M | ---- | ---- | ---- | ---- | 3.14%853M | ---- | ---- | ---- |
| Other operating expenses | -32.52%249M | 5.59%397M | 10.42%-533M | -14.84%264M | -18.73%295M | 23.41%369M | 17.50%376M | 6.15%-595M | -1.90%310M | 10.67%363M |
| Operating profit | -44.81%1.48B | -21.68%11.43B | -42.42%2.14B | -27.09%2.89B | -11.29%3.72B | -1.40%2.68B | 61.66%14.59B | 19.83%3.72B | 53.74%3.97B | 90.45%4.19B |
| Net non-operating interest income expense | -3.37%-829M | -36.49%-3.35B | -11.25%-870M | -34.83%-840M | -46.92%-836M | -67.43%-802M | -130.98%-2.45B | -124.07%-782M | -110.47%-623M | -204.28%-569M |
| Non-operating interest expense | 3.37%829M | 36.49%3.35B | 11.25%870M | 34.83%840M | 46.92%836M | 67.43%802M | 130.98%2.45B | 124.07%782M | 110.47%623M | 204.28%569M |
| Other net income (expense) | -27.43%246M | 27.92%1.13B | 84.96%246M | 15.15%304M | 3.93%238M | 32.42%339M | -24.25%881M | 3.91%133M | 3.13%264M | -57.59%229M |
| Gain on sale of security | ---- | 160.22%56M | ---- | ---- | ---- | ---- | -144.71%-93M | ---- | ---- | ---- |
| Special income (charges) | ---- | -42.42%19M | ---- | ---- | ---- | ---- | -54.17%33M | ---- | ---- | ---- |
| -Less:Other special charges | ---- | 42.42%-19M | ---- | ---- | ---- | ---- | 54.17%-33M | ---- | ---- | ---- |
| Other non- operating income (expenses) | -27.43%246M | 11.80%1.05B | -11.40%171M | 15.15%304M | 3.93%238M | 32.42%339M | 6.57%941M | 226.97%193M | 3.13%264M | -57.59%229M |
| Income before tax | -59.59%895M | -29.29%9.21B | -50.57%1.52B | -34.69%2.36B | -19.00%3.12B | -11.15%2.22B | 42.64%13.02B | 6.52%3.07B | 42.02%3.61B | 50.78%3.85B |
| Income tax | -94.24%27M | -27.06%2.09B | -64.78%249M | -1.73%625M | -24.22%751M | -12.66%469M | 43.05%2.87B | 9.95%707M | -2.75%636M | 114.97%991M |
| Earnings from equity interest net of tax | -150.00%-1M | -442.86%-24M | -1,500.00%-28M | -50.00%1M | 0.00%2M | 100.00%2M | -30.00%7M | 0.00%2M | --2M | -66.67%2M |
| Net income | -50.40%867M | -30.20%7.09B | -47.55%1.24B | -41.76%1.73B | -17.17%2.37B | -10.68%1.75B | 42.43%10.16B | 5.53%2.37B | 57.67%2.97B | 36.34%2.86B |
| Net income continuous Operations | -50.40%867M | -30.20%7.09B | -47.55%1.24B | -41.76%1.73B | -17.17%2.37B | -10.68%1.75B | 42.43%10.16B | 5.53%2.37B | 57.67%2.97B | 36.34%2.86B |
| Minority interest income | 33.33%-2M | -9.09%-12M | -200.00%-3M | 50.00%-3M | -100.00%-2M | -50.00%-3M | -1,000.00%-11M | 50.00%-1M | -700.00%-6M | 0.00%-1M |
| Net income attributable to the parent company | -50.37%869M | -30.16%7.1B | -47.45%1.25B | -41.77%1.73B | -17.13%2.37B | -10.62%1.75B | 42.56%10.17B | 5.48%2.37B | 58.07%2.98B | 36.32%2.86B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -50.37%869M | -30.16%7.1B | -47.45%1.25B | -41.77%1.73B | -17.13%2.37B | -10.62%1.75B | 42.56%10.17B | 5.48%2.37B | 58.07%2.98B | 36.32%2.86B |
| Basic earnings per share | -48.80%3.2 | -26.06%25.73 | -44.94%4.57 | -38.28%6.32 | -11.66%8.56 | -5.02%6.25 | 48.59%34.8 | 10.96%8.3 | 65.16%10.24 | 41.46%9.69 |
| Diluted earnings per share | -48.80%3.19 | -26.02%25.62 | -44.92%4.55 | -38.33%6.29 | -11.61%8.53 | -4.89%6.23 | 48.75%34.63 | 11.02%8.26 | 65.58%10.2 | 41.70%9.65 |
| Dividend per share | 10.20%1.62 | 16.44%5.88 | 8.89%1.47 | 17.60%1.47 | 17.60%1.47 | 22.50%1.47 | 15.83%5.05 | 19.47%1.35 | 10.62%1.25 | 19.05%1.25 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now